{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:59:16Z","timestamp":1789012756596,"version":"build-2803163510"},"reference-count":227,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T00:00:00Z","timestamp":1561593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009036","name":"Strategic International Collaborative Research Program","doi-asserted-by":"publisher","award":["16jm0310026h0004"],"award-info":[{"award-number":["16jm0310026h0004"]}],"id":[{"id":"10.13039\/501100009036","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Recent progress in the research for underlying mechanisms in neurodegenerative diseases, including Alzheimer disease (AD), Parkinson disease (PD), and amyotrophic lateral sclerosis (ALS) has led to the development of potentially effective treatment, and hence increased the need for useful biomarkers that may enable early diagnosis and therapeutic monitoring. The deposition of abnormal proteins is a pathological hallmark of neurodegenerative diseases, including \u03b2-amyloid in AD, \u03b1-synuclein in PD, and the transactive response DNA\/RNA binding protein of 43kDa (TDP-43) in ALS. Furthermore, progression of the disease process accompanies the spreading of abnormal proteins. Extracellular proteins and RNAs, including mRNA, micro RNA, and circular RNA, which are present as a composite of exosomes or other forms, play a role in cell\u2013cell communication, and the role of extracellular molecules in the cell-to-cell spreading of pathological processes in neurodegenerative diseases is now in the spotlight. Therefore, extracellular proteins and RNAs are considered potential biomarkers of neurodegenerative diseases, in particular ALS, in which RNA dysregulation has been shown to be involved in the pathogenesis. Here, we review extracellular proteins and RNAs that have been scrutinized as potential biomarkers of neurodegenerative diseases, and discuss the possibility of extracellular RNAs as diagnostic and therapeutic monitoring biomarkers of sporadic ALS.<\/jats:p>","DOI":"10.3390\/ijms20133148","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T10:56:05Z","timestamp":1561632965000},"page":"3148","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Extracellular RNAs as Biomarkers of Sporadic Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases"],"prefix":"10.3390","volume":"20","author":[{"given":"Takashi","family":"Hosaka","sequence":"first","affiliation":[{"name":"Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenari","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Tamaoka","sequence":"additional","affiliation":[{"name":"Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Kwak","sequence":"additional","affiliation":[{"name":"Department of Molecular Neuropathogenesis, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,6,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/bs.ircmb.2017.04.002","article-title":"Micrornas in neurodegenerative diseases","volume":"334","author":"Quinlan","year":"2017","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Maniati, M.S., Maniati, M., Yousefi, T., Ahmadi-Ahangar, A., and Tehrani, S.S. (2019). New insights into the role of micrornas and long noncoding rnas in most common neurodegenerative diseases. J. Cell. Biochem.","DOI":"10.1002\/jcb.28361"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.bbrc.2016.09.090","article-title":"The role of extracellular vesicles in neurodegenerative diseases","volume":"483","author":"Quek","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Biomarkers Definitions Working Group (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin. Pharmacol. Ther., 69, 89\u201395.","DOI":"10.1067\/mcp.2001.113989"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Van den Berg, L.H., Sorenson, E., Gronseth, G., Macklin, E.A., Andrews, J., Baloh, R.H., Benatar, M., Berry, J.D., Chio, A., and Corcia, P. (2019). Revised airlie house consensus guidelines for design and implementation of als clinical trials. Neurology.","DOI":"10.1212\/WNL.0000000000007242"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Rappa, G., Puglisi, C., Santos, M.F., Forte, S., Memeo, L., and Lorico, A. (2019). Extracellular vesicles from thyroid carcinoma: The new frontier of liquid biopsy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20051114"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: Exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.molmed.2014.04.003","article-title":"The role of extracellular vesicles in the progression of neurodegenerative disease and cancer","volume":"20","author":"Candelario","year":"2014","journal-title":"Trends Mol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Caruso Bavisotto, C., Scalia, F., Marino Gammazza, A., Carlisi, D., Bucchieri, F., Conway de Macario, E., Macario, A.J.L., Cappello, F., and Campanella, C. (2019). Extracellular vesicle-mediated cell(-)cell communication in the nervous system: Focus on neurological diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020434"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/17482960802566824","article-title":"Prognostic factors in als: A critical review","volume":"10","author":"Chio","year":"2009","journal-title":"Amyotroph. Lateral. Scler."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000351153","article-title":"Global epidemiology of amyotrophic lateral sclerosis: A systematic review of the published literature","volume":"41","author":"Chio","year":"2013","journal-title":"Neuroepidemiology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrneurol.2013.203","article-title":"The epidemiology of als: A conspiracy of genes, environment and time","volume":"9","author":"Hardiman","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding als: From genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.lfs.2017.12.016","article-title":"New insights into the gene expression associated to amyotrophic lateral sclerosis","volume":"193","author":"Alarcon","year":"2018","journal-title":"Life Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"Tdp-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated tdp-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.clinph.2007.09.143","article-title":"Electrodiagnostic criteria for diagnosis of als","volume":"119","author":"Dengler","year":"2008","journal-title":"Clin. Neurophysiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1080\/14660820052415862","article-title":"Risk factors in the early diagnosis of als: European epidemiological studies","volume":"1","year":"2000","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.clineuro.2011.11.026","article-title":"Factors affecting the diagnostic delay in amyotrophic lateral sclerosis","volume":"114","author":"Cellura","year":"2012","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/jnnp.51.2.165","article-title":"Preclinical and subclinical events in motor neuron disease","volume":"51","author":"Swash","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jnnp.2009.183525","article-title":"Incidence of amyotrophic lateral sclerosis in europe","volume":"81","author":"Logroscino","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Kim, K.M., Abdelmohsen, K., Mustapic, M., Kapogiannis, D., and Gorospe, M. (2017). Rna in extracellular vesicles. Wiley Interdiscip. Rev. RNA, 8.","DOI":"10.1002\/wrna.1413"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1042\/BST20120019","article-title":"Extracellular small rnas: What, where, why?","volume":"40","author":"Hoy","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"37043","DOI":"10.18632\/oncotarget.6158","article-title":"Altered microrna profiles in cerebrospinal fluid exosome in parkinson disease and alzheimer disease","volume":"6","author":"Gui","year":"2015","journal-title":"Oncotarget"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ricci, C., Marzocchi, C., and Battistini, S. (2018). Micrornas as biomarkers in amyotrophic lateral sclerosis. Cells, 7.","DOI":"10.3390\/cells7110219"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3389\/fgene.2018.00712","article-title":"Rna dysregulation in amyotrophic lateral sclerosis","volume":"9","author":"Butti","year":"2018","journal-title":"Front. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tcb.2008.11.003","article-title":"Shedding microvesicles: Artefacts no more","volume":"19","author":"Cocucci","year":"2009","journal-title":"Trends Cell Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mrnas and micrornas is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"ra81","DOI":"10.1126\/scisignal.2000610","article-title":"Delivery of microrna-126 by apoptotic bodies induces cxcl12-dependent vascular protection","volume":"2","author":"Zernecke","year":"2009","journal-title":"Sci. Signal"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-013-1084-8","article-title":"Biogenesis of extracellular vesicles (ev): Exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies","volume":"113","author":"Akers","year":"2013","journal-title":"J. Neurooncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"Micrornas are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating micrornas independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1093\/nar\/gkq601","article-title":"Export of micrornas and microrna-protective protein by mammalian cells","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Dluzen, D.F., Noren Hooten, N., and Evans, M.K. (2017). Extracellular rna in aging. Wiley Interdiscip. Rev. RNA, 8.","DOI":"10.1002\/wrna.1385"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/s41467-017-01196-x","article-title":"Coding and noncoding landscape of extracellular rna released by human glioma stem cells","volume":"8","author":"Wei","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microrna biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e1463","DOI":"10.1002\/wrna.1463","article-title":"Noncoding rnas in alzheimer\u2019s disease","volume":"9","author":"Idda","year":"2018","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrm.2015.4","article-title":"A-to-i editing of coding and non-coding rnas by adars","volume":"17","author":"Nishikura","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1474-4422(11)70286-1","article-title":"Non-coding rnas with essential roles in neurodegenerative disorders","volume":"11","author":"Salta","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e1478","DOI":"10.1002\/wrna.1478","article-title":"A 360 degrees view of circular rnas: From biogenesis to functions","volume":"9","author":"Wilusz","year":"2018","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/cr.2015.82","article-title":"Circular rna is enriched and stable in exosomes: A promising biomarker for cancer diagnosis","volume":"25","author":"Li","year":"2015","journal-title":"Cell Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.celrep.2016.03.058","article-title":"The biogenesis of nascent circular rnas","volume":"15","author":"Zhang","year":"2016","journal-title":"Cell Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.celrep.2014.12.019","article-title":"Analysis of intron sequences reveals hallmarks of circular rna biogenesis in animals","volume":"10","author":"Ivanov","year":"2015","journal-title":"Cell Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"14741","DOI":"10.1038\/ncomms14741","article-title":"Fus affects circular rna expression in murine embryonic stem cell-derived motor neurons","volume":"8","author":"Errichelli","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1261\/rna.035667.112","article-title":"Circular rnas are abundant, conserved, and associated with alu repeats","volume":"19","author":"Jeck","year":"2013","journal-title":"RNA"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Salzman, J., Gawad, C., Wang, P.L., Lacayo, N., and Brown, P.O. (2012). Circular rnas are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030733"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.molcel.2015.03.027","article-title":"Circular rnas in the mammalian brain are highly abundant, conserved, and dynamically expressed","volume":"58","author":"Stottmeister","year":"2015","journal-title":"Mol. Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"38907","DOI":"10.1038\/srep38907","article-title":"Circrna accumulation in the aging mouse brain","volume":"6","author":"Gruner","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"11172","DOI":"10.1073\/pnas.0603838103","article-title":"Alzheimer\u2019s disease beta-amyloid peptides are released in association with exosomes","volume":"103","author":"Rajendran","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"Csf and blood biomarkers for the diagnosis of alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid \u03b2-amyloid 42 and tau proteins as biomarkers of alzheimer-type pathologic changes in the brain","volume":"66","author":"Tapiola","year":"2009","journal-title":"Arch. Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jnnp.2010.207183","article-title":"Cerebrospinal fluid biomarkers in the differential diagnosis of alzheimer\u2019s disease from other cortical dementias","volume":"82","author":"Lamari","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1021\/cn500101j","article-title":"Plasma abeta but not tau is related to brain pib retention in early alzheimer\u2019s disease","volume":"5","author":"Tzen","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-beta biomarkers for alzheimer\u2019s disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/alzrt163","article-title":"Plasma tau levels in alzheimer\u2019s disease","volume":"5","author":"Zetterberg","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","article-title":"Plasma phospho-tau181 increases with alzheimer\u2019s disease clinical severity and is associated with tau- and amyloid-positron emission tomography","volume":"14","author":"Mielke","year":"2018","journal-title":"Alzheimers Dement"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic alzheimer\u2019s disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nat. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","article-title":"Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in csf","volume":"67","author":"Rosengren","year":"1996","journal-title":"J. Neurochem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1212\/WNL.0000000000004667","article-title":"Serum neurofilament light in familial alzheimer disease: A marker of early neurodegeneration","volume":"89","author":"Weston","year":"2017","journal-title":"Neurology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of plasma neurofilament light with neurodegeneration in patients with alzheimer disease","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jneumeth.2018.10.025","article-title":"Blood-based biomarkers for alzheimer\u2019s disease-an update","volume":"319","author":"Zetterberg","year":"2019","journal-title":"J. Neurosci. Methods"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s41398-017-0035-0","article-title":"Association between serum neuron-specific enolase, age, overweight, and structural mri patterns in 901 subjects","volume":"7","author":"Hoffmann","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF02260939","article-title":"Neuron specific enolase in cerebrospinal fluid: A biochemical marker for neuronal degeneration in dementia disorders?","volume":"8","author":"Blennow","year":"1994","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"ref_69","first-page":"93","article-title":"Cerebrospinal fluid neuron-specific enolase: A further marker of alzheimer\u2019s disease?","volume":"23","author":"Palumbo","year":"2008","journal-title":"Funct. Neurol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neulet.2014.04.007","article-title":"Elevated levels of cerebrospinal fluid neuron-specific enolase (nse) in alzheimer\u2019s disease","volume":"570","author":"Schmidt","year":"2014","journal-title":"Neurosci. Lett."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0304-3940(94)11110-5","article-title":"Cerebrospinal fluid neuron-specific enolase in alzheimer\u2019s disease and vascular dementia","volume":"183","author":"Parnetti","year":"1995","journal-title":"Neurosci. Lett."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2011.00001","article-title":"Discriminatory analysis of biochip-derived protein patterns in csf and plasma in neurodegenerative diseases","volume":"3","author":"Rosen","year":"2011","journal-title":"Front. Aging Neurosci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-7-6","article-title":"Serum levels of s100b and nse proteins in alzheimer\u2019s disease patients","volume":"7","author":"Chaves","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1373\/clinchem.2008.104497","article-title":"The brain injury biomarker vlp-1 is increased in the cerebrospinal fluid of alzheimer disease patients","volume":"54","author":"Lee","year":"2008","journal-title":"Clin. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.22448","article-title":"Visinin-like protein-1: Diagnostic and prognostic biomarker in alzheimer disease","volume":"70","author":"Tarawneh","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/jnc.12331","article-title":"Csf levels of the neuronal injury biomarker visinin-like protein-1 in alzheimer\u2019s disease and dementia with lewy bodies","volume":"127","author":"Luo","year":"2013","journal-title":"J. Neurochem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00406-013-0405-4","article-title":"Heart-type fatty acid binding protein and vascular endothelial growth factor: Cerebrospinal fluid biomarker candidates for alzheimer\u2019s disease","volume":"263","author":"Guo","year":"2013","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2012-120787","article-title":"Microglial markers are elevated in the prodromal phase of alzheimer\u2019s disease and vascular dementia","volume":"33","author":"Olsson","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","article-title":"Ykl-40: A novel prognostic fluid biomarker for preclinical alzheimer\u2019s disease","volume":"68","author":"Perrin","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JAD-140240","article-title":"Relationship between beta-secretase, inflammation and core cerebrospinal fluid biomarkers for alzheimer\u2019s disease","volume":"42","author":"Alcolea","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12017-011-8147-9","article-title":"Cerebrospinal fluid microglial markers in alzheimer\u2019s disease: Elevated chitotriosidase activity but lack of diagnostic utility","volume":"13","author":"Mattsson","year":"2011","journal-title":"Neuromolecular Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/brain\/awq035","article-title":"Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis","volume":"133","author":"Comabella","year":"2010","journal-title":"Brain"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.bbadis.2016.06.001","article-title":"Are circulating micrornas peripheral biomarkers for alzheimer\u2019s disease?","volume":"1862","author":"Kumar","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1573406411666151030112140","article-title":"Mirnas as circulating biomarkers for alzheimer\u2019s disease and parkinson\u2019s disease","volume":"12","author":"Mushtaq","year":"2016","journal-title":"Med. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clinbiochem.2018.05.020","article-title":"Micro rna as a potential blood-based epigenetic biomarker for alzheimer\u2019s disease","volume":"58","author":"Fransquet","year":"2018","journal-title":"Clin. Biochem."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Swarbrick, S., Wragg, N., Ghosh, S., and Stolzing, A. (2019). Systematic review of mirna as biomarkers in alzheimer\u2019s disease. Mol. Neurobiol., 1\u201312.","DOI":"10.1007\/s12035-019-1500-y"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.jmb.2019.01.046","article-title":"Emerging role of micrornas in dementia","volume":"431","author":"Ramakrishna","year":"2019","journal-title":"J. Mol. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/jnnp-2015-311890","article-title":"The prediagnostic phase of parkinson\u2019s disease","volume":"87","author":"Noyce","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mcn.2018.12.005","article-title":"Cerebrospinal fluid biomarker for parkinson\u2019s disease: An overview","volume":"97","author":"Maass","year":"2018","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbrc.2006.08.024","article-title":"Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with parkinson\u2019s disease","volume":"349","author":"Tokuda","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"33691","DOI":"10.1074\/jbc.M112.379792","article-title":"Novel one-step immunoassays to quantify alpha-synuclein: Applications for biomarker development and high-throughput screening","volume":"287","author":"Bidinosti","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1038\/srep02540","article-title":"A longitudinal study on alpha-synuclein in blood plasma as a biomarker for parkinson\u2019s disease","volume":"3","author":"Foulds","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","article-title":"Dj-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of parkinson\u2019s disease","volume":"133","author":"Hong","year":"2010","journal-title":"Brain"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","article-title":"A-synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: A cohort study","volume":"10","author":"Mollenhauer","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for parkinson\u2019s disease","volume":"20","author":"Salem","year":"2006","journal-title":"FASEB J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","article-title":"Detection of elevated levels of \u03b1-synuclein oligomers in csf from patients with parkinson disease","volume":"75","author":"Tokuda","year":"2010","journal-title":"Neurology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","article-title":"Development of a biochemical diagnosis of parkinson disease by detection of alpha-synuclein misfolded aggregates in cerebrospinal fluid","volume":"74","author":"Shahnawaz","year":"2017","journal-title":"JAMA Neurol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","article-title":"Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or parkinsonian disorders","volume":"69","author":"Hall","year":"2012","journal-title":"Arch. Neurol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/mds.27110","article-title":"Diagnostic utility of cerebrospinal fluid alpha-synuclein in parkinson\u2019s disease: A systematic review and meta-analysis","volume":"32","author":"Eusebi","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/jnnp-2014-309562","article-title":"A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes","volume":"86","author":"Magdalinou","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based nfl: A biomarker for differential diagnosis of parkinsonian disorder","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s12264-017-0183-5","article-title":"Biomarkers for parkinson\u2019s disease: Recent advancement","volume":"33","author":"Lotankar","year":"2017","journal-title":"Neurosci. Bull."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/ane.12590","article-title":"Cerebrospinal fluid biomarkers for parkinson\u2019s disease - a systematic review","volume":"135","author":"Andersen","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00221-017-4989-1","article-title":"Micrornas in parkinson\u2019s disease","volume":"235","author":"Singh","year":"2017","journal-title":"Exp. Brain Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fnins.2018.00625","article-title":"Circulating mirnas as diagnostic biomarkers for parkinson\u2019s disease","volume":"12","author":"Roser","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1212\/01.wnl.0000203129.82104.07","article-title":"Identification of potential csf biomarkers in als","volume":"66","author":"Pasinetti","year":"2006","journal-title":"Neurology"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Von Neuhoff, N., Oumeraci, T., Wolf, T., Kollewe, K., Bewerunge, P., Neumann, B., Brors, B., Bufler, J., Wurster, U., and Schlegelberger, B. (2012). Monitoring csf proteome alterations in amyotrophic lateral sclerosis: Obstacles and perspectives in translating a novel marker panel to the clinic. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0044401"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.3892\/etm.2016.3210","article-title":"Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis","volume":"11","author":"Chen","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1038\/s41598-019-40632-4","article-title":"Combined tissue-fluid proteomics to unravel phenotypic variability in amyotrophic lateral sclerosis","volume":"9","author":"Leoni","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1001\/archneur.65.11.1481","article-title":"Tdp-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"65","author":"Steinacker","year":"2008","journal-title":"Arch. Neurol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-008-0456-1","article-title":"Increased tdp-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"117","author":"Kasai","year":"2009","journal-title":"Acta Neuropathol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/17482968.2010.541263","article-title":"Elevated csf tdp-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value","volume":"12","author":"Noto","year":"2011","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/00207454.2013.848440","article-title":"Differential diagnosis of amyotrophic lateral sclerosis from guillain-barre syndrome by quantitative determination of tdp-43 in cerebrospinal fluid","volume":"124","author":"Hosokawa","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/21678421.2014.905606","article-title":"Limited role of free tdp-43 as a diagnostic tool in neurodegenerative diseases","volume":"15","author":"Feneberg","year":"2014","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3389\/fneur.2018.01167","article-title":"Diagnostic and prognostic performance of neurofilaments in als","volume":"9","author":"Poesen","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"a018309","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and neurofilament proteins in health and disease","volume":"9","author":"Yuan","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1212\/01.wnl.0000203120.85850.54","article-title":"Axonal damage markers in cerebrospinal fluid are increased in als","volume":"66","author":"Brettschneider","year":"2006","journal-title":"Neurology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1471-4159.2009.06386.x","article-title":"Immunoreactivity of the phosphorylated axonal neurofilament h subunit (pnf-h) in blood of als model rodents and als patients: Evaluation of blood pnf-h as a potential als biomarker","volume":"111","author":"Boylan","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_119","first-page":"12","article-title":"Neurofilaments in the diagnosis of motoneuron diseases: A prospective study on 455 patients","volume":"87","author":"Steinacker","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","article-title":"Neurofilament markers for als correlate with extent of upper and lower motor neuron disease","volume":"88","author":"Poesen","year":"2017","journal-title":"Neurology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1212\/WNL.0000000000004761","article-title":"Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis","volume":"90","author":"Feneberg","year":"2018","journal-title":"Neurology"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fneur.2018.00726","article-title":"Diagnostic performance of neurofilaments in chinese patients with amyotrophic lateral sclerosis: A prospective study","volume":"9","author":"Li","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/nan.12511","article-title":"Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with amyotrophic lateral sclerosis","volume":"45","author":"Gille","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jnnp-2018-318704","article-title":"Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis","volume":"90","author":"Verde","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1242\/jcs.173864","article-title":"Inhibition of motor neuron death in vitro and in vivo by a p75 neurotrophin receptor intracellular domain fragment","volume":"129","author":"Matusica","year":"2016","journal-title":"J. Cell Sci."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Shepheard, S.R., Chataway, T., Schultz, D.W., Rush, R.A., and Rogers, M.L. (2014). The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087398"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1212\/WNL.0000000000003741","article-title":"Urinary p75ecd: A prognostic, disease progression, and pharmacodynamic biomarker in als","volume":"88","author":"Shepheard","year":"2017","journal-title":"Neurology"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1038\/s41598-017-05430-w","article-title":"Urinary extracellular domain of neurotrophin receptor p75 as a biomarker for amyotrophic lateral sclerosis in a chinese cohort","volume":"7","author":"Jia","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.tins.2012.03.007","article-title":"P75 neurotrophin receptor signaling in nervous system injury and degeneration: Paradox and opportunity","volume":"35","author":"Ibanez","year":"2012","journal-title":"Trends Neurosci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3389\/fnins.2017.00711","article-title":"Unraveling the role of rna mediated toxicity of c9orf72 repeats in c9-ftd\/als","volume":"11","author":"Kumar","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1212\/WNL.0000000000004109","article-title":"The evolving genetic risk for sporadic als","volume":"89","author":"Gibson","year":"2017","journal-title":"Neurology"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Van Rheenen, W., Diekstra, F.P., Harschnitz, O., Westeneng, H.J., van Eijk, K.R., Saris, C.G.J., Groen, E.J.N., van Es, M.A., Blauw, H.M., and van Vught, P.W.J. (2018). Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0198874"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Saris, C.G., Horvath, S., van Vught, P.W., van Es, M.A., Blauw, H.M., Fuller, T.F., Langfelder, P., DeYoung, J., Wokke, J.H., and Veldink, J.H. (2009). Weighted gene co-expression network analysis of the peripheral blood from amyotrophic lateral sclerosis patients. BMC Genom., 10.","DOI":"10.1186\/1471-2164-10-405"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1038\/s41598-018-20679-5","article-title":"Long non-coding and coding rnas characterization in peripheral blood mononuclear cells and spinal cord from amyotrophic lateral sclerosis patients","volume":"8","author":"Gagliardi","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1742-2094-8-114","article-title":"Vascular endothelial growth factor-a and chemokine ligand (ccl2) genes are upregulated in peripheral blood mononuclear cells in indian amyotrophic lateral sclerosis patients","volume":"9","author":"Gupta","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000443664","article-title":"Alteration of motor protein expression involved in bidirectional transport in peripheral blood mononuclear cells of patients with amyotrophic lateral sclerosis","volume":"16","author":"Kazmierczak","year":"2016","journal-title":"Neurodegener. Dis."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1155\/2012\/824692","article-title":"Two potential biomarkers identified in mesenchymal stem cells and leukocytes of patients with sporadic amyotrophic lateral sclerosis","volume":"32","author":"Nachmany","year":"2012","journal-title":"Dis. Markers"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12031-017-1014-x","article-title":"Neurotrophin expression in lymphocytes: A powerful indicator of degeneration in parkinson\u2019s disease, amyotrophic lateral sclerosis and ataxia","volume":"64","author":"Sadanand","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/bies.20092","article-title":"Vegf: Once regarded as a specific angiogenic factor, now implicated in neuroprotection","volume":"26","author":"Storkebaum","year":"2004","journal-title":"Bioessays"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/88842","article-title":"Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration","volume":"28","author":"Oosthuyse","year":"2001","journal-title":"Nat. Genet."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1523\/JNEUROSCI.4926-08.2009","article-title":"Astrocyte-derived mcp-1 mediates neuroprotective effects of noradrenaline","volume":"29","author":"Madrigal","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.1523\/JNEUROSCI.20-17-06374.2000","article-title":"Kif5c, a novel neuronal kinesin enriched in motor neurons","volume":"20","author":"Kanai","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1007\/s11064-013-1160-7","article-title":"Dynactin deficiency in the cns of humans with sporadic als and mice with genetically determined motor neuron degeneration","volume":"38","author":"Chudy","year":"2013","journal-title":"Neurochem. Res."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2165\/11534530-000000000-00000","article-title":"Neuroplasticity\u2014exercise-induced response of peripheral brain-derived neurotrophic factor: A systematic review of experimental studies in human subjects","volume":"40","author":"Knaepen","year":"2010","journal-title":"Sports Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4161\/cc.6.1.3665","article-title":"Cyfip2, a direct p53 target, is leptomycin-b sensitive","volume":"6","author":"Jackson","year":"2007","journal-title":"Cell Cycle"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/1258","article-title":"A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability","volume":"19","author":"Woitach","year":"1998","journal-title":"Nat. Genet."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s12272-013-0161-z","article-title":"Role of chemokine ccl2 and its receptor ccr2 in neurodegenerative diseases","volume":"36","author":"Bose","year":"2013","journal-title":"Arch. Pharm. Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.neulet.2018.09.055","article-title":"Association of vascular endothelial growth factor levels in csf and cerebral glucose metabolism across the alzheimer\u2019s disease spectrum","volume":"687","author":"Wang","year":"2018","journal-title":"Neurosci. Lett."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12031-018-1100-8","article-title":"Postmortem brain, cerebrospinal fluid, and blood neurotrophic factor levels in alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"65","author":"Du","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fnmol.2017.00127","article-title":"Motomirs: Mirnas in motor neuron function and disease","volume":"10","author":"Hawley","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13195-017-0316-0","article-title":"Circulating brain-enriched micrornas as novel biomarkers for detection and differentiation of neurodegenerative diseases","volume":"9","author":"Sheinerman","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fnins.2017.00731","article-title":"Small rna sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed mirnas related to neural and glial activity","volume":"11","author":"Waller","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fnmol.2018.00106","article-title":"Differential expression of several mirnas and the host genes aatk and dnm2 in leukocytes of sporadic als patients","volume":"11","author":"Vrabec","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1172\/JCI62636","article-title":"Modulating inflammatory monocytes with a unique microrna gene signature ameliorates murine als","volume":"122","author":"Butovsky","year":"2012","journal-title":"J. Clin. Invest."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5414\/NP300889","article-title":"Circulating micrornas as biomarkers of muscle differentiation and atrophy in als","volume":"35","author":"Tasca","year":"2016","journal-title":"Clin. Neuropathol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fnmol.2018.00288","article-title":"Dysregulation of micrornas and target genes networks in peripheral blood of patients with sporadic amyotrophic lateral sclerosis","volume":"11","author":"Liguori","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fnmol.2016.00069","article-title":"Aberration of mirnas expression in leukocytes from sporadic amyotrophic lateral sclerosis","volume":"9","author":"Chen","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Toivonen, J.M., Manzano, R., Olivan, S., Zaragoza, P., Garcia-Redondo, A., and Osta, R. (2014). Microrna-206: A potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089065"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2017.03.027","article-title":"Serum mirnas mir-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (als)","volume":"55","author":"Waller","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fneur.2019.00400","article-title":"A systematic review of suggested molecular strata, biomarkers and their tissue sources in als","volume":"10","author":"Vijayakumar","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_161","first-page":"697","article-title":"Microrna-9 regulates axon extension and branching by targeting map1b in mouse cortical neurons","volume":"25","author":"Bonev","year":"2012","journal-title":"Nat. Neurosci."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1523\/JNEUROSCI.4330-10.2011","article-title":"Microrna mir-9 modifies motor neuron columns by a tuning regulation of foxp1 levels in developing spinal cords","volume":"31","author":"Otaegi","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ydbio.2013.12.023","article-title":"Microrna-9 promotes the switch from early-born to late-born motor neuron populations by regulating onecut transcription factor expression","volume":"386","author":"Luxenhofer","year":"2014","journal-title":"Dev. Biol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"13111","DOI":"10.1073\/pnas.1006151107","article-title":"Mirna malfunction causes spinal motor neuron disease","volume":"107","author":"Haramati","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brainresbull.2016.01.011","article-title":"Microrna-9 controls apoptosis of neurons by targeting monocyte chemotactic protein-induced protein 1 expression in rat acute spinal cord injury model","volume":"121","author":"Xu","year":"2016","journal-title":"Brain Res. Bull."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1101\/gad.1519107","article-title":"The microrna mir-124 antagonizes the anti-neural rest\/scp1 pathway during embryonic cns development","volume":"21","author":"Visvanathan","year":"2007","journal-title":"Genes Dev."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1074\/jbc.M112.410944","article-title":"Neuronal exosomal mirna-dependent translational regulation of astroglial glutamate transporter glt1","volume":"288","author":"Morel","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Ishtiaq, M., Campos-Melo, D., Volkening, K., and Strong, M.J. (2014). Analysis of novel nefl mrna targeting micrornas in amyotrophic lateral sclerosis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0085653"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mcn.2013.10.006","article-title":"Hspb1 silences translation of pdz-rhogef by enhancing mir-20a and mir-128 expression to promote neurite extension","volume":"57","author":"Sun","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1093\/hmg\/ddu350","article-title":"Smn regulates axonal local translation via mir-183\/mtor pathway","volume":"23","author":"Kye","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7150\/ijbs.10921","article-title":"Mir-206, a key modulator of skeletal muscle development and disease","volume":"11","author":"Ma","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10048-014-0420-2","article-title":"Mir-338-3p is over-expressed in blood, cfs, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients","volume":"15","author":"Annunziata","year":"2014","journal-title":"Neurogenetics"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gene.2012.07.058","article-title":"A mirna signature in leukocytes from sporadic amyotrophic lateral sclerosis","volume":"508","author":"Guida","year":"2012","journal-title":"Gene"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1140481","article-title":"A microrna feedback circuit in midbrain dopamine neurons","volume":"317","author":"Kim","year":"2007","journal-title":"Science"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000369692","article-title":"Mir-133b promotes neurite outgrowth by targeting rhoa expression","volume":"35","author":"Lu","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/mus.26106","article-title":"Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis","volume":"58","author":"Raheja","year":"2018","journal-title":"Muscle Nerve"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"278","DOI":"10.14336\/AD.2018.0917","article-title":"Collagen xix alpha 1 improves prognosis in amyotrophic lateral sclerosis","volume":"10","author":"Calvo","year":"2019","journal-title":"Aging Dis."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jns.2016.06.046","article-title":"Micrornas-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis","volume":"368","author":"Avansini","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"9538","DOI":"10.1038\/s41598-017-10161-z","article-title":"Potential therapeutic targets for als: Mir206, mir208b and mir499 are modulated during disease progression in the skeletal muscle of patients","volume":"7","author":"Baranzini","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/17482968.2011.649760","article-title":"Spinal cord markers in als: Diagnostic and biomarker considerations","volume":"13","author":"Bede","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cell.2018.05.022","article-title":"A network of noncoding regulatory rnas acts in the mammalian brain","volume":"174","author":"Kleaveland","year":"2018","journal-title":"Cell"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000089620","article-title":"Excitotoxicity and amyotrophic lateral sclerosis","volume":"2","author":"Dewil","year":"2005","journal-title":"Neurodegener. Dis."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.expneurol.2015.09.019","article-title":"Excitotoxicity in als: Overstimulation, or overreaction?","volume":"275","author":"King","year":"2016","journal-title":"Exp. Neurol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.410240314","article-title":"The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis","volume":"24","author":"Plaitakis","year":"1988","journal-title":"Ann. Neurol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410280106","article-title":"Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis","volume":"28","author":"Rothstein","year":"1990","journal-title":"Ann. Neurol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/neur.1995.0026","article-title":"Csf and plasma amino acid levels in motor neuron disease: Elevation of csf glutamate in a subset of patients","volume":"4","author":"Shaw","year":"1995","journal-title":"Neurodegeneration"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-510X(01)00661-X","article-title":"Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: A reappraisal using a new hplc method with coulometric detection in a large cohort of patients","volume":"193","author":"Bensimon","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1212\/WNL.56.2.270","article-title":"Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis","volume":"56","author":"Ferrarese","year":"2001","journal-title":"Neurology"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cca.2010.01.016","article-title":"Metabolomic analysis of serum by (1) h nmr spectroscopy in amyotrophic lateral sclerosis","volume":"411","author":"Kumar","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.clineuro.2007.10.018","article-title":"Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: The effect of riluzole treatment","volume":"110","author":"Andreadou","year":"2008","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00702-012-0806-y","article-title":"Csf markers in amyotrophic lateral sclerosis","volume":"119","author":"Tarasiuk","year":"2012","journal-title":"J. Neural Transm. (Vienna)"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10571-014-0107-0","article-title":"High plasma glutamate levels are associated with poor functional outcome in acute ischemic stroke","volume":"35","author":"Meng","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Rajda, C., Pukoli, D., Bende, Z., Majlath, Z., and Vecsei, L. (2017). Excitotoxins, mitochondrial and redox disturbances in multiple sclerosis. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020353"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199205283262204","article-title":"Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis","volume":"326","author":"Rothstein","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410380114","article-title":"Selective loss of glial glutamate transporter glt-1 in amyotrophic lateral sclerosis","volume":"38","author":"Rothstein","year":"1995","journal-title":"Ann. Neurol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0896-6273(00)80997-6","article-title":"Aberrant rna processing in a neurodegenerative disease: The cause for absent eaat2, a glutamate transporter, in amyotrophic lateral sclerosis","volume":"20","author":"Lin","year":"1998","journal-title":"Neuron"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neulet.2011.04.047","article-title":"Increased rna editing in eaat2 pre-mrna from amyotrophic lateral sclerosis patients: Involvement of a cryptic polyadenylation site","volume":"497","author":"Flomen","year":"2011","journal-title":"Neurosci. Lett."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1073\/pnas.90.14.6591","article-title":"Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity","volume":"90","author":"Rothstein","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/(SICI)1097-4547(19960615)44:6<551::AID-JNR5>3.0.CO;2-A","article-title":"Inhibition of glutamate uptake induces progressive accumulation of extracellular glutamate and neuronal damage in rat cortical cultures","volume":"44","author":"Velasco","year":"1996","journal-title":"J. Neurosci. Res."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1126\/science.276.5319.1699","article-title":"Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter glt-1","volume":"276","author":"Tanaka","year":"1997","journal-title":"Science"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1471-4159.2004.02383.x","article-title":"Ampa receptor activation, but not the accumulation of endogenous extracellular glutamate, induces paralysis and motor neuron death in rat spinal cord in vivo","volume":"89","author":"Corona","year":"2004","journal-title":"J. Neurochem."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuint.2008.09.015","article-title":"Chronic elevation of extracellular glutamate due to transport blockade is innocuous for spinal motoneurons in vivo","volume":"54","author":"Tovar","year":"2009","journal-title":"Neurochem. Int."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.bjp.0706949","article-title":"Transporters for l-glutamate: An update on their molecular pharmacology and pathological involvement","volume":"150","author":"Beart","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-510X(99)00196-3","article-title":"The rna of the glutamate transporter eaat2 is variably spliced in amyotrophic lateral sclerosis and normal individuals","volume":"170","author":"Meyer","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/1531-8249(200005)47:5<641::AID-ANA12>3.0.CO;2-I","article-title":"Glutamate uptake is decreased in platelets from alzheimer\u2019s disease patients","volume":"47","author":"Ferrarese","year":"2000","journal-title":"Ann. Neurol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s100720170049","article-title":"Decreased platelet glutamate uptake and genetic risk factors in patients with parkinson\u2019s disease","volume":"22","author":"Ferrarese","year":"2001","journal-title":"Neurol. Sci."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neuint.2005.09.009","article-title":"Increased glutamine synthetase but normal eaat2 expression in platelets of als patients","volume":"48","author":"Bos","year":"2006","journal-title":"Neurochem. Int."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/mus.10186","article-title":"Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis","volume":"26","author":"Heath","year":"2002","journal-title":"Muscle Nerve"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1523\/JNEUROSCI.16-13-04069.1996","article-title":"Motor neurons are selectively vulnerable to ampa\/kainate receptor-mediated injury in vitro","volume":"16","author":"Carriedo","year":"1996","journal-title":"J. Neurosci."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.bbadis.2006.05.002","article-title":"The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis","volume":"1762","author":"Bogaert","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0896-6273(92)90120-3","article-title":"Divalent ion permeability of ampa receptor channels is dominated by the edited form of a single subunit","volume":"8","author":"Burnashev","year":"1992","journal-title":"Neuron"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/379460a0","article-title":"A mammalian rna editing enzyme","volume":"379","author":"Melcher","year":"1996","journal-title":"Nature"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-biochem-060208-105251","article-title":"Functions and regulation of rna editing by adar deaminases","volume":"79","author":"Nishikura","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/4561","article-title":"Neurological dysfunctions in mice expressing different levels of the q\/r site-unedited ampar subunit glur-b","volume":"2","author":"Feldmeyer","year":"1999","journal-title":"Nat. Neurosci."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/35017558","article-title":"Point mutation in an ampa receptor gene rescues lethality in mice deficient in the rna-editing enzyme adar2","volume":"406","author":"Higuchi","year":"2000","journal-title":"Nature"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0896-6273(02)00760-2","article-title":"A-to-i editing: New and old sites, functions and speculations","volume":"35","author":"Seeburg","year":"2002","journal-title":"Neuron"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/427801a","article-title":"Glutamate receptors: Rna editing and death of motor neurons","volume":"427","author":"Kawahara","year":"2004","journal-title":"Nature"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.nbd.2011.12.033","article-title":"Profound downregulation of the rna editing enzyme adar2 in als spinal motor neurons","volume":"45","author":"Hideyama","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neures.2005.09.006","article-title":"Underediting of glur2 mrna, a neuronal death inducing molecular change in sporadic als, does not occur in motor neurons in als1 or sbma","volume":"54","author":"Kawahara","year":"2006","journal-title":"Neurosci. Res."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00401-010-0678-x","article-title":"Tdp-43 pathology in sporadic als occurs in motor neurons lacking the rna editing enzyme adar2","volume":"120","author":"Aizawa","year":"2010","journal-title":"Acta Neuropathol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/ncomms2303","article-title":"A role for calpain-dependent cleavage of tdp-43 in amyotrophic lateral sclerosis pathology","volume":"3","author":"Yamashita","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Hosaka, T., Yamashita, T., Teramoto, S., Hirose, N., Tamaoka, A., and Kwak, S. (2018). Adar2-dependent a-to-i rna editing in the extracellular linear and circular rnas. Neurosci. Res.","DOI":"10.1016\/j.neures.2018.11.005"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jocn.2015.12.039","article-title":"Deficient rna-editing enzyme adar2 in an amyotrophic lateral sclerosis patient with a fus(p525l) mutation","volume":"32","author":"Aizawa","year":"2016","journal-title":"J. Clin. Neurosci."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41467-017-02729-0","article-title":"C9orf72 repeat expansion causes vulnerability of motor neurons to ca(2+)-permeable ampa receptor-mediated excitotoxicity","volume":"9","author":"Selvaraj","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-019-01999-w","article-title":"Adar2 mislocalization and widespread rna editing aberrations in c9orf72-mediated als\/ftd","volume":"138","author":"Moore","year":"2019","journal-title":"Acta Neuropathol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/emmm.201302935","article-title":"Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous aav9-adar2 delivery to motor neurons","volume":"5","author":"Yamashita","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"28649","DOI":"10.1038\/srep28649","article-title":"The ampa receptor antagonist perampanel robustly rescues amyotrophic lateral sclerosis (als) pathology in sporadic als model mice","volume":"6","author":"Akamatsu","year":"2016","journal-title":"Sci. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/13\/3148\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:01:50Z","timestamp":1760187710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/13\/3148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,27]]},"references-count":227,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2019,7]]}},"alternative-id":["ijms20133148"],"URL":"https:\/\/doi.org\/10.3390\/ijms20133148","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,27]]}}}